InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+57.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Ingram Douglas S, 董事长兼首席执行官. Insider active across 2 companies, notably Sarepta Therapeutics, Inc.. Aggregated, 6 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €2.5m. Activity tracked since 26 June 2021. The latest transaction was filed on 16 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ingram Douglas S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
7,819 股0Common StockSEC:0001190644-25-000004:0
50,000 股0Common StockSEC:0001193125-25-313184:0
38,396 股@ US$20.09100.0% 占其流量Common StockSEC:0001628280-25-004478:0
10,081 股@ US$78.5711.2% 占其流量Common StockSEC:0001209191-23-054441:0
标准退出：2024年2月1日 (T+90)
25,026 股@ US$79.9447.6% 占其流量Common StockSEC:0001209191-21-065246:0
标准退出：2022年2月15日 (T+90)
17,812 股@ US$80.4032.3% 占其流量Common StockSEC:0001209191-21-043582:0
6 条申报中的 6 条
About Ingram Douglas S
Douglas S. Ingram is the President and CEO of Sarepta Therapeutics, Inc. He leads the company with a strategic vision, overseeing operations and business development. His leadership is essential for innovation and growth at Sarepta Therapeutics, Inc.
